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ABSTRACT Amyloid is associated with a number of diseases including Alzheimer’s, Huntington’s, Parkinson’s, and the
spongiform encephalopathies. Amyloid ﬁbrils have been formed in vitro from both disease and nondisease related proteins, but
the latter requires extremes of pH, heat, or the presence of a chaotropic agent. We show, using ﬂuorescence spectroscopy,
electron microscopy, and solid-state NMR spectroscopy, that the a-helical type I antifreeze protein from the winter ﬂounder
forms amyloid ﬁbrils at pH 4 and 7 upon freezing and thawing. Our results demonstrate that the freezing of some proteins may
accelerate the formation of amyloid ﬁbrils.
INTRODUCTION
Amyloidosis describes the presence of proteinaceous
deposits with speciﬁc morphological, staining, and structural
characteristics. The existence of these insoluble and
proteolytically resistant deposits can seriously interfere with
normal organ function (Pepys, 2001). Amyloid deposits
have been associated with a number of diseases, including
Alzheimer’s, Huntington’s, Parkinson’s, AA amyloidosis,
type II diabetes, dialysis-related amyloidosis, and scrapie.
When stained with traditional dyes, amyloid deposits appear
amorphous. However, when stained with Congo Red and
viewed through cross-polarizing lenses, amyloid deposits
show a characteristic green birefringence, which suggests an
underlying structure. Under an electron microscope, the
ﬁbrils appear unbranched and have a diameter of 50–130 A˚
(Serpell et al., 1997). X-ray diffraction studies reveal that
these ﬁbrils have a ‘‘cross-b’’ structure, wherein the protein
aggregates as b-strands forming a sheet that winds around
the ﬁbril axis in a helical manner (Serpell et al., 1997). Solid-
state NMR work has reﬁned the ﬁbril model by showing that
the b-amyloid peptides form parallel b-sheets (Balbach
et al., 2002; Benzinger et al., 2000), although an antiparallel
arrangement has also been detected for a shorter b-amyloid
peptide (Balbach et al., 2000). Other NMR experiments have
demonstrated that the backbone conformation differs from
the classical b-sheet (Costa et al., 1997; Spencer et al.,
1991). Despite these similar morphological features, no
consistent similarity in sequence, structure, or function has
been found for proteins that are able to form amyloid ﬁbrils
(Kisilevsky, 2000; Chiti et al., 2001; Dobson, 1999).
One of the ﬁrst clues that the formation of amyloid ﬁbrils
may not be limited to the disease state was the study on the
SH3 domain of the phosphatidylinositol kinase (Guijarro
et al., 1998). Exposure of this protein to low pH resulted in
the formation of a gel with morphological properties similar
to amyloid ﬁbrils. This has also been repeated with a number
of other, nonpathological proteins including ﬁbronectin
(Litvinovich et al., 1998), cold-shock protein B (Gross
et al., 1999), and myoglobin (Fandrich et al., 2001).
Type I antifreeze protein (AFP, also known as thermal
hysteresis protein and as ice-structuring protein) is found
at relatively high concentrations in the circulatory system
(10–15 mg/mL) and in the skin of ﬁsh living in subzero
seawater, and protects the organism from macromolecular
ice growth by adsorption inhibition (Fletcher et al., 2001).
Structural studies have revealed that the 37-residue protein
forms an a-helical structure (Sicheri and Yang, 1995; see
Fig. 1). The role of hydrogen bonds and van-der-Waals
forces in ice binding has been extensively studied (Jia and
Davies, 2002); however, their relative contribution to the
interaction remains unclear.
During our studies of the AFP mechanism, we found that
the winter ﬂounder type I AFP in solution formed a
translucent gel upon freezing and thawing at physiological
pH and below. It has been established that gel formation of a
protein at or above the critical concentration of polymer-
ization (Harper and Lansbury, 1997) may indicate the
formation of amyloid ﬁbrils. To determine if the gel was
amyloidotic in nature, we examined three properties speciﬁc
to amyloid: morphology by electron microscopy, ﬂuores-
cence staining by the amyloid-speciﬁc dye Thioﬂavin T
(ThT), and structural characteristics by solid-state 13C-NMR
spectroscopy. The data presented here demonstrate that type
I AFP can be converted into amyloid ﬁbrils upon freezing
and thawing, conditions appropriate to its physiological
function.
MATERIALS AND METHODS
Preparation of AFP ﬁbril
The wild-type winter ﬂounder AFP HPLC-6 was synthesized according to
standard solid-phase peptide synthesis methods as described previously
(Hodges et al., 1988). For 13C-labeled samples, a 13Ca-alanine residue
(2-13C-alanine, Cambridge Isotopes Laboratories, Andover, MA) was
incorporated at position 17 (Fig. 1).
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For the preparation of unlabeled antifreeze protein for use with the
ﬂuorescence experiments, 3 mg of protein was dissolved in 31 mL of H2O.
The pH was adjusted to ;4 by the addition of 9 mL of 100 mM NaOH,
resulting in a ﬁnal protein concentration of 75 mg/mL (23 mM). An aliquot
of the sample was stored at 48C as a negative control. The remaining aliquots
were frozen and thawed between one and three times.
For the preparation of labeled protein for NMR experiments, 9 mg of
13Ca-Ala17 type I AFP was dissolved in 90 mL of H2O. To adjust the pH to
;4, 30 mL of 100 mM NaOH was added, giving a ﬁnal concentration of 75
mg/mL (23 mM). The sample was frozen and thawed as indicated in Fig. 4.
Electron microscopy
Electron micrographs were acquired on a Hitachi Transmission Electron
Microscope H-7000 (Tokyo) operating at a 75-kV excitation voltage. The
sample was prepared by applying 3 mL of ;50 mg/mL protein gel on a
Formvar grid and subsequently dried. The gel was negatively stained with
2% uranyl acetate.
ThT ﬂuorescence
ThT ﬂuorescence was performed as described by LeVine (1999). Brieﬂy,
1 mg of protein was mixed with 1 mL of 5 mM ThT in 50 mM glycine-
NaOH, pH 8.5. The ﬂuorescence of the sample was measured on a Shimadzu
RF5301-PC ﬂuorescence spectrophotometer (Kyoto, Japan) with the
emission intensity traced from 460 to 520 nm with a 10-nm slit width
using an excitation wavelength of 450 nm with a 5-nm slit width. Relative
ﬂuorescence values are reported at 482 nm. The three negative controls
consisted of ThT alone, AFP ﬁbril alone, or AFP in solution with 5 mM ThT.
NMR spectroscopy
The NMR spectra were collected at 7.04 Tesla corresponding to a 13C
Larmor frequency of 75.416 MHz on a Varian Unity Spectrometer (Palo
Alto, CA) equipped with a Varian/Chemagnetics double-resonance MAS
probe with a 5.0-mm PENCIL-I MAS rotor. For the 13C-CP/MAS
experiments, the cross-polarization contact time was 3.0 ms during which
the 1H decoupling ﬁeld strength was 78.1 kHz. During acquisition, the
decoupling ﬁeld strength was reduced to 55.3 kHz. 13,312 transients were
collected with a recycle delay of 5 s. The proton 908 pulsewidth was
calibrated to be 3.6 ms. For the 13C-MAS experiments, a 1H decoupler ﬁeld
strength of 15.6 kHz was applied to 144 or 512 transients with a recycle
delay of 3 s. All MAS experiments were collected with 2972 complex data
points, a sweepwidth of 37,140 Hz, and performed with the sample spinning
at 3.333 kHz. Chemical shifts were referenced relative to the carbon
chemical shift of 2,29-dimethyl-2-silapentane-5-sulfonate (0 ppm; see
Wishart et al., 1995).
RESULTS
Electron microscopy reveals unbranched ﬁbrils
Electron microscopy was used to examine uranyl acetate
stained gel preparations of type I AFP. Fig. 2 shows
unbranched ﬁbrils that are ;50 A˚ in diameter, which is
in agreement with previous studies on ﬁbrils in amyloid
deposits (Serpell et al., 1997). In addition, studies have
shown that these ﬁbrils associate into larger, mature ﬁbrils,
where several protoﬁlaments coil around one another (Chiti
et al., 1999). This is illustrated for type I AFP in Fig. 2 B.
Type I AFP gel binds the ﬂuorescent dye ThT
To provide further evidence that the type I AFP ﬁbrils were
amyloidotic in nature, we examined the AFP gel in the
FIGURE 1 Structure of type I AFP. A ribbon diagram of the type I AFP
crystal structure (PDB code 1wfb, chain B; see Sicheri and Yang, 1995). The
protein is 37 residues long, with 23 residues consisting of alanine. The
location of the single 13Ca-alanine is labeled.
FIGURE 2 Transmission electron micrographs of AFP gel. Uranyl
acetate stained preparations of the AFP gel were examined under an
electron microscope to determine its nature. (A) Fibrils formed after freezing
and thawing a 75 mg/mL, pH 4 sample three times. The arrows show an
individual ﬁbril with a diameter of ;50 A˚ . (B) Protoﬁlaments. Scale bars,
100 nm.
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presence of the ﬂuorescent dye ThT. ThT undergoes a
speciﬁc excitation and emission redshift when bound to
amyloid ﬁbrils (LeVine, 1999). Congo Red (Puchtler et al.,
1962), a stain commonly used for detecting amyloid ﬁbrils,
was not employed inasmuch as it has been shown to bind
soluble proteins including b-helical proteins (Khurana et al.,
2001). Fig. 3 shows a bar graph demonstrating the increase
in ﬂuorescence intensity over time with successive freeze-
and-thaw cycles. Immediately after one freeze/thaw cycle,
there is little change in the ﬂuorescence intensity. Subse-
quent freeze/thaw cycles increased the ﬂuorescence signal,
suggesting that more of the protein was being converted into
amyloid ﬁbril. Similar results were obtained with type I AFP
at pH 7, 100 mM NaCl (data not shown). In addition, the
warming and cooling of a type I AFP solution between 58C
and 258C did not cause a gel to form. These two results
demonstrate that it is the freeze/thaw procedure and not the
low pH or temperature cycling that promote amyloid
formation. The control sample of type I AFP that was not
frozen had approximately the same ﬂuorescence as the ThT
dye alone. Interestingly this sample, upon storage at 48C for
several days before the ﬂuorescence experiments, had also
become gel-like, but was transparent and not ﬁrm like the
translucent, amyloidotic gel.
Solid-state 13C-NMR spectroscopy shows a
b-sheet structure
The third assessment for amyloid formation is the presence
of b-sheet structure. To follow changes in protein con-
formation during freezing and thawing, 13C-NMR was used
as 13Ca chemical shifts are especially sensitive to secondary
structure; a positive deviation from random coil chemical
shifts (51.7 ppm for alanine) is indicative of an a-helical
conformation whereas a negative deviation is indicative of
b-sheet conformation (Wishart et al., 1994). Because 23 of
the 37 residues in type I AFP are alanine, the protein was
synthesized with a single 13Ca label at position Ala17 to
simplify analysis (Fig. 1). Solid-state 13C-1D magic-angle
spinning direct polarization (13C-MAS) experiments re-
vealed that before freezing, the protein was a-helical (54.1
ppm chemical shift at 208C) (Fig. 4 A). This value is similar
to the previously measured chemical shift of 54.5 ppm at
218C (Graether et al., 2001). Upon freezing, the signal was
lost (Fig. 4 A). A cross-polarization/magic-angle spinning
(13C-CP/MAS) spectrum subsequently taken at 208C (Fig.
4 B) indicated that the peptide remained a-helical in ice with
a chemical shift of 55.1 ppm. This also agrees with ex-
periments demonstrating that the protein remains a-helical
when supercooled (Graether et al., 2001) and rules out
denaturation during the freezing process as the cause of ﬁbril
formation.
Upon thawing the sample at 208C, the 13C-MAS spectrum
revealed a lower intensity than before freezing. This intensity
decreased over 20 h (at 208C) during which a 13C-CP/MAS
spectrum was taken. Three peaks were found centered at
54.0, 51.5, and 50.9 ppm. The peak at 54.0 ppm is consistent
with an a-helical structure, whereas the peaks at 51.5 and
50.9 are consistent with a b-sheet structure. The hetero-
geneity in b-sheet chemical shifts may indicate that the ﬁbril
is dynamic. Refreezing of the sample produced a spectrum
with chemical shifts of 55.0 and 51.4 ppm. The peak at 51.4
ppm is consistent with the chemical shift observed for an
alanine residue in a parallel b-sheet structure found in
amyloidotic prion protein fragments (Laws et al., 2001).
Further thawing and freezing of the protein results in a total
loss of intensity in the 13C-MAS experiment indicating a loss
of free protein. Concomitantly, the 13C-CP/MAS experi-
ments revealed an increase in the amount of protein in the
parallel b-sheet conformation. Interestingly, at a certain
point the peak at 55 ppm appears to change little upon
freezing and thawing. This was also observed for the prion
protein and may be due to the trapping of the a-helical form
of AFP in the gel matrix.
DISCUSSION
Conformational stability and amyloidogenesis
It has been shown that destabilization of the native
conformation of several proteins render it prone to amyloid
formation (Kelly, 1998; Dobson, 2001; Chiti et al., 1999). To
induce amyloid formation, these proteins require unusual
conditions such as extremes of pH, high concentrations of
chaotropic agents, such as TFE, or high temperatures
(Guijarro et al., 1998; Chiti et al., 2000; Fandrich et al.,
2001; Chiti et al., 2001; Bucciantini et al., 2002; Litvinovich
FIGURE 3 ThT ﬂuorescence of ﬁbrillar AFP and controls. Samples of
the AFP gel after various stages of freezing and thawing were treated with
the amyloid-speciﬁc dye ThT. A bar graph shows the normalized
ﬂuorescence emission maximum at 482 nm after excitation at 450 nm.
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et al., 1998). For type I AFP, amyloid formation can occur at
neutral pH and physiological salt concentrations suggesting
that the chemical environment is not responsible for amyloid
formation for this protein.
Antifreeze proteins have a number of unusual properties.
Analysis of the type I AFP amino-acid sequence using the
program SEQSEE (Wishart et al., 1994) predicts that due to
its high hydrophobicity (68% of the residues are hydro-
phobic), the protein forms multimers and is therefore not
expected to be soluble. Nonetheless, type I AFP can dissolve
to a high concentration (>50 mg/mL) and remain mono-
meric and a-helical, presumably because of its high alanine
content (23 of 37 residues). Interestingly, a de novo designed
helical peptide was shown to form ﬁbrils at neutral pH
(Fezoui et al., 2000). However, this peptide appeared to be
only partially folded at pH 7.4 whereas at pH 3.6, where the
peptide was most stable, ﬁbril formation was not favored.
This is in direct contrast to type I AFP, which was able to
form ﬁbrils at neural and acidic pHs, and appears to have an
increase in stability as the temperature is decreased (Graether
et al., 2001).
For the most part, amyloid ﬁbril formation is associated
with disease states. However, there are examples where
amyloid formation can be beneﬁcial to an organism. In
Escherichia coli and Salmonella spp., a class of proteins
known as curli are responsible for forming extracellular
amyloid-like ﬁbers which are responsible for colonization
of inert surfaces, bioﬁlm formation, and mediation of binding
to host proteins (Chapman et al., 2002). Fish embryos of
Austrofundulus limnaeus are surrounded by an egg
envelope composed of two proteins that together form a
structure similar to amyloid ﬁbrils. This amyloid chorion
protects the ﬁsh embryo from mechanical disruption, serves
as a barrier to polyspermy, microbes, and low molecular
weight solutes, and is able to help prevent dehydration of the
embryo by preventing water loss (Podrabsky et al., 2001).
It is possible that a conformational change of type I AFP
at physiological concentrations may play a role in ice
inhibition. Indeed, the insect antifreeze proteins have a
parallel b-helix structure (Graether et al., 2000; Liou et al.,
2000), a motif that has been shown to bind Congo Red
(Khurana et al., 2001). Possibly the remarkable properties of
AFP (such as alignment of proteins on the ice surface)
promote the ordered aggregation of neighboring molecules
into the parallel b-sheet structure, that, under high concen-
trations, can form amyloid. We are currently investigating
FIGURE 4 13C-NMR spectra of type I AFP.
The conformation of the type I AFP was
examined after sequential freeze/thaw cycles by
following the 13Ca-Ala17 chemical shift. Values
greater than 51.7 ppm indicate that the residue is
in an a-helical conformation, whereas lesser
values indicate b-strand conformation. Numbers
indicate the chemical shift of the 13Ca-Ala17
peak(s). (A) 13C-MAS direct polarization: (i)
Before ﬁrst freeze, 208C; (ii) Frozen,208C; (iii)
30 min after ﬁrst thaw, 208C; (iv) 20 h after ﬁrst
thaw, 208C; and (v) After second thaw, 208C. (B)
13C-CP/MAS spectra of AFP at208C (left) and
208C (right). The arrows indicate the spectra
after sequential freeze (dashed line) and thaw
(solid line) cycles. The number indicates the
cycle of freezing (F1–5) or thawing (T1–5).
Chemical shifts are referenced to 2,29-dimethyl-
2-silapentane-5-sulfonate at 0 ppm (Wishart
et al., 1995).
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how this may be involved in AFP function and ﬁbril
formation.
Amyloidogenesis and applications of AFPs
The type I AFP is found in the circulatory system of ﬁsh at a
concentration of 10-15 mg/mL (Fletcher et al., 2001). The
relatively low physiological concentration of the protein and
its ability to bind to membranes (Tomczak et al., 2002) may
prevent it from self-association. However, there is a question
concerning the freezing of ﬁsh for long-term storage, and
whether other potentially ﬁbril-forming proteins could
similarly form amyloid-like ﬁbrils upon freezing and
thawing. Inasmuch as type I AFP can form amyloid, its
use in applications (Fletcher et al., 1999) such as cryo-
preservation, cryosurgery, as a food additive, and in expres-
sion in transgenic organisms needs to be addressed (Crevel
et al., 2002).
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